Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study

被引：0
|
作者：
N B Leighl
J Bennouna
J Yi
N Moore
J Hambleton
H Hurwitz
机构：
[1] Princess Margaret Hospital,Division of Medical Oncology
[2] Centre René Gauducheau,Division of Medical Oncology
[3] Genentech,Division of Medical Oncology
[4] Inc.,undefined
[5] Hoffman-La Roche,undefined
[6] Inc.,undefined
[7] Duke University School of Medicine,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
bevacizumab; non-small cell lung cancer; colorectal cancer; anticoagulation; haemorrhage; safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：413 / 418
页数：5
相关论文
共 50 条
  • [1] Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
    Leighl, N. B.
    Bennouna, J.
    Yi, J.
    Moore, N.
    Hambleton, J.
    Hurwitz, H.
    BRITISH JOURNAL OF CANCER, 2011, 104 (03) : 413 - 418
  • [2] A MULTICENTER STUDY OF PULMONARY EMBOLISM PATIENTS TREATED WITH REDUCED- OR FULL-DOSE ALTEPLASE
    Melamed, Roman
    Tierney, David
    Xia, Ranran
    Brown, Caitlin
    Mara, Kristin
    Sidebottom, Abbey
    Lillyblad, Matthew
    Wiley, Brandon
    Khapov, Ivan
    Ognjen, Gajic
    CRITICAL CARE MEDICINE, 2024, 52
  • [3] Local control in patients with unresectable pancreatic cancer treated with radiation and concurrent full-dose gemcitabine
    Ben-Josef, E.
    Murphy, J. D.
    Adusumilli, S.
    Lawrence, T. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S172 - S172
  • [4] RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
    Nicolazzo, Chiara
    Belardinilli, Francesca
    Vestri, Annarita
    Magri, Valentina
    De Renzi, Gianluigi
    De Meo, Michela
    Caponnetto, Salvatore
    Di Nicolantonio, Federica
    Cortesi, Enrico
    Giannini, Giuseppe
    Gazzaniga, Paola
    CANCERS, 2022, 14 (03)
  • [5] Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
    Fukuda, Satoshi
    Niisato, Yusuke
    Tsuji, Miki
    Fukuda, Soma
    Hagiwara, Yuya
    Onoda, Tsubasa
    Suzuki, Hirosumi
    Tange, Yoshitaka
    Yamada, Takeshi
    Yamamoto, Yoshiyuki
    Moriwaki, Toshikazu
    ANTICANCER RESEARCH, 2023, 43 (05) : 2085 - 2090
  • [6] Pharmacokinetics of cisplatin in an esophageal cancer patient on hemodialysis who was treated with a full-dose cisplatin-fluorouracil regimen: A case report
    Amagai, Hiroyuki
    Murakami, Kentaro
    Sakata, Haruhito
    Uesato, Masaya
    Hayano, Koichi
    Kano, Masayuki
    Fujishiro, Takeshi
    Toyozumi, Takeshi
    Yoshihide, Senba
    Yamamoto, Kohei
    Hayashi, Hideki
    Matsubara, Hisahiro
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (07) : 1767 - 1775
  • [7] RANDOMISED PHASE III STUDY OF BEVACIZUMAB plus CHEMOTHERAPY BEYOND PROGRESSION IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: TML STUDY KRAS SUBGROUP FINDINGS
    Van Cutsem, Eric
    Maria Vieitez, Jose
    Bouche, Olivier
    Osterlund, Pia
    Bennouna, Jaafar
    Andre, Thierry
    Sastre, Javier
    Alonso-Orduna, Vicente
    Kubicka, Stefan
    Greil, Richard
    von Moos, Roger
    Reyes-Rivera, Irmarie
    Scherer, Stefan
    Bendahmane, Belguendouz
    Arnold, Dirk
    ANNALS OF ONCOLOGY, 2012, 23 : 15 - 15
  • [8] CLINICAL OUTCOMES IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM ARIES OBSERVATIONAL COHORT STUDY AND CONFIRMATION OF BRITE DATA ON BEVACIZUMAB BEYOND PROGRESSION
    Cohn, A.
    Bekaii-Saab, T.
    Bendell, J.
    Hurwitz, H.
    Kozloff, M.
    Roach, N.
    Tezcan, H.
    Feng, S.
    Sing, A.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 11 - 11
  • [9] PHASE II TRIAL OF FULL-DOSE GEMCITABINE AND BEVACIZUMAB IN COMBINATION WITH ATTENUATED THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY IN PATIENTS WITH LOCALIZED PANCREATIC CANCER
    Small, William, Jr.
    Mulcahy, Mary F.
    Rademaker, Alfred
    Bentrem, David J.
    Benson, Al B.
    Weitner, Bing Bing
    Talamonti, Mark S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 476 - 482
  • [10] A phase I study of oxaliplatin, full-dose gemcitabine and concurrent radiation therapy in patients with pancreatic cancer.
    Desai, S. P.
    Ben-Josef, E.
    Lawrence, T. J.
    Francis, I. R.
    Greenson, J. K.
    Alfred, C. E.
    Colletti, L. M.
    Simeone, D. M.
    Normolle, D. P.
    Zalupski, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 204S - 204S
12345